PCI The Journeys Within

Current Edition

Frankfurt 2027 – 12/10/26
ramusmedical
Current features

Transforming Clinical Operations through the Synergy of Generative and Agentic AI

Artificial Intelligence (AI) continues to evolve at an unprecedented pace, reshaping the way organisations operate, innovate, and make decisions. Among its most tran...
Continue Reading →
Current features

Recruitment and Retention in Clinical Trials: A Participant-Centred Approach

Recruitment and retention are among the most persistent operational challenges in clinical trials, directly influencing timelines, budgets and data quality. In the U...
Continue Reading →
Current features

Exploring the Use of Patient Reported Outcomes for Primary Endpoints

Barbara Arch, Principal Statistician at Phastar, discusses the use opportunities and challenges of using electronic patient reported outcomes (ePROs) for primary end...
Continue Reading →
Current features

Rethinking Recruitment and Retention in Competitive Oncology Clinical Trials

In the current pharmaceutical environment, where the industry faces a potential patent cliff ranging anywhere from $236–400B in revenue,1,2 sponsors are under mounti...
Continue Reading →
Current features

Paediatric Oncology Trials in Spain: Meeting Urgent Needs with Innovation and Speed

In September 2025, Spain’s national medicines agency, AEMPS, announced a significant regulatory change: the expansion of its fast-track assessment procedure to inclu...
Continue Reading →
Current features

Independent Data Monitoring Committee Member Selection: Practice and Challenges

Independent Data Monitoring Committees (IDMCs) have become an essential part of drug development. Not every clinical trial needs to have an IDMC, but the number of t...
Continue Reading →
Current features

The Future of AI Initiatives in Clinical Research

Even before the boom of AI following the launch of generative AI platforms in 2022, AI was already reshaping clinical research and drug development, with early adopt...
Continue Reading →
Regional News

START, Together with HM Hospitals, Inaugurates Spain’s First Paediatric Onco-haematology Clinical Research Unit

New START site at HM Montepríncipe University Hospital offers clinical trial access for children with cancer San Antonio, TX / Madrid, Spain  — The START Centre f...
Continue Reading →
Regional News

Quotient Sciences and Biorasi Partner to Accelerate Early Phase Clinical Trials to Patient Proof-of-concept

NOTTINGHAM, UK— Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Biorasi, a global clinical research organization (C...
Continue Reading →
Regional News

WCG Unveils 2025 Site Challenges Report to Fuel Clinical Research Transformation

CARY, NC – WCG, a global leader in providing solutions that measurably improve and accelerate clinical research, today announced the release of its highly anticipate...
Continue Reading →
Quotient